Clinical trial of prevention for PCI-related myocardial infarction evaluating index of microvascular resistance in stable coronary artery disease. -Effect of Fasudil, a selective Rho-kinase inhibitor
Phase 2
Recruiting
- Conditions
- stable coronary artery disease
- Registration Number
- JPRN-jRCTs021180031
- Lead Sponsor
- Jun Takahashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
(1)stable coronary artery disease
(2)stenosis in left coronary artery
(3)pressure wire enable to pass the lesion
(4)20 years old and older
(5)male or female
Exclusion Criteria
(1) severe anemia or infection, malignancy, decompensated congestive heart failure
(2) previous myocardial infarction in the target vessel
(3) target vessel is a donar or recipient of collateral artery
(4)systolic blood pressure under 80mmHg
(5)bronchial asthma or allergy for adenosin triphosphate
(6) left main coronary trunk lesion or severe stenosis with contrast delay
(7) severe renal or liver dysfunction
(8) allergy for Fasudil
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method